Neoantigen Based Monoclonal Antibodies in Combination with Checkpoint Inhibitors

Time: 2:00 pm
day: Day Two

Details:

  • Identifying tumor neoantigens
  • Determining the function of antibodies targeting the neoantigens
  • Justification for combining with checkpoint inhibitors

Speakers: